Asset Planning Corporation’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-280
| Closed | -$294K | – | 45 |
|
|
2024
Q3 | $294K | Hold |
280
| – | – | 0.19% | 39 |
|
|
2024
Q2 | $294K | Hold |
280
| – | – | 0.22% | 35 |
|
|
2024
Q1 | $269K | Hold |
280
| – | – | 0.2% | 37 |
|
|
2023
Q4 | $246K | Hold |
280
| – | – | 0.19% | 36 |
|
|
2023
Q3 | $230K | Hold |
280
| – | – | 0.18% | 37 |
|
|
2023
Q2 | $201K | Hold |
280
| – | – | 0.15% | 40 |
|
|
2023
Q1 | $230K | Hold |
280
| – | – | 0.18% | 34 |
|
|
2022
Q4 | $202K | Buy |
+280
| New | +$202K | 0.17% | 38 |
|